Semaglutide Market Forecast 2027–2032: Valuation to Hit USD 64.51 Billion as Diabetes and Weight Management Demand Expands, Reports Mordor Intelligence

The semaglutide market is projected to grow from USD 36.1 billion in 2027 to USD 64.51 billion by 2032, at a CAGR of 12.31%. North America leads with 45.64% market share, while Asia-Pacific is the fastest-growing region at 16.4% CAGR. Growth is driven by rising obesity and diabetes prevalence, expanded formulations, and broader access channels, though high costs and reimbursement limitations remain challenges.